Sanofi (SNYNF)
OTC: SNYNF
· Real-Time Price · USD
99.50
-2.07 (-2.04%)
At close: Jun 13, 2025, 2:33 PM
Revenue by Geography
| Period Ending | Dec 31, 2023 |
|---|---|
| Europe Revenue | 10.39B |
| Europe Revenue Growth | n/a |
| France Revenue | 2.38B |
| France Revenue Growth | n/a |
| North America Revenue | 19.22B |
| North America Revenue Growth | n/a |
| Reportable Geographical Zones Revenue | 43.07B |
| Reportable Geographical Zones Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 2.22B | 1.24B | 2.68B | 5.26B | 2.6B | 5.51B | 2.58B | 2.58B | 2.61B | 2.9B | 2.64B | 2.57B | 2.38B | 2.76B | 2.27B | 2.34B | 2.19B | 2.6B | 2.18B | 2.27B | 2.34B | 2.74B | 2.31B | 2.46B | 2.38B | 2.73B | 2.31B | 2.51B | 2.31B | 2.7B | 2.31B | 2.57B | 2.48B | 2.6B | 2.27B | 2.4B | 2.21B | 2.48B | 2.46B | 2.65B | 2.44B |
| Selling, General, and Administrative Revenue Growth | +78.90% | -53.67% | -49.03% | +101.92% | -52.72% | +113.65% | +0.16% | -1.23% | -9.95% | +9.49% | +2.72% | +8.20% | -13.74% | +21.66% | -2.95% | +6.47% | -15.65% | +19.20% | -3.66% | -3.29% | -14.43% | +18.43% | -6.02% | +3.49% | -12.97% | +18.18% | -7.86% | +8.43% | -14.31% | +16.59% | -9.89% | +3.63% | -4.80% | +14.47% | -5.13% | +8.36% | -10.88% | +0.85% | -7.06% | +8.61% | n/a |
| Research and Development Revenue | 1.81B | 2.12B | 1.85B | 3.42B | 1.72B | 3.54B | 1.66B | 1.63B | 1.56B | 1.82B | 1.74B | 1.66B | 1.49B | 1.58B | 1.44B | 1.4B | 1.27B | 1.52B | 1.32B | 1.35B | 1.34B | 1.69B | 1.36B | 1.59B | 1.39B | 1.68B | 1.46B | 1.48B | 1.28B | 1.46B | 1.34B | 1.36B | 1.31B | 1.44B | 1.22B | 1.28B | 1.24B | 1.36B | 1.35B | 1.29B | 1.2B |
| Research and Development Revenue Growth | -14.68% | +14.42% | -45.90% | +99.13% | -51.37% | +112.57% | +2.02% | +4.29% | -14.26% | +5.01% | +4.70% | +11.35% | -6.06% | +9.84% | +3.29% | +10.35% | -16.49% | +14.76% | -2.29% | +0.90% | -20.52% | +23.97% | -14.30% | +14.58% | -17.46% | +14.85% | -0.95% | +15.23% | -12.57% | +9.17% | -1.25% | +3.74% | -8.91% | +17.69% | -4.53% | +3.56% | -9.46% | +0.66% | +5.04% | +7.59% | n/a |